UQ3-40715-67938
2 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 915 / CA
- Registered
- 2021-10-25
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-25
Registered in v-safe
-
2021-10-25
Dose 2 — Moderna
- 2021-10-25
- 2021-10-26
-
2021-10-27
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Fatigue or tirednessFree text: Baby is super activeMedDRA releases: 2024-11 · check-in free text available
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-25 | Moderna | No |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Baby is super active
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release